-
Signature
-
/s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne
-
Issuer symbol
-
RPRX
-
Transactions as of
-
11 Feb 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
13 Feb 2026, 16:03:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Coyne Terrance P. |
EVP & CFO |
C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK |
/s/ Sean Weisberg, as Attorney-in-Fact for Terrance P. Coyne |
13 Feb 2026 |
0001814876 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RPRX |
Class A Ordinary Shares |
Award |
$0 |
+26,626 |
+116% |
$0.000000 |
49,511 |
11 Feb 2026 |
TPC RP EPA1 LLC |
F1 |
| holding |
RPRX |
Class A Ordinary Shares |
|
|
|
|
|
164,580 |
11 Feb 2026 |
By TPC RP 2021, LLC |
|
| holding |
RPRX |
Class A Ordinary Shares |
|
|
|
|
|
24,170 |
11 Feb 2026 |
By Spouse's IRA |
|
| holding |
RPRX |
Class A Ordinary Shares |
|
|
|
|
|
23,270 |
11 Feb 2026 |
By IRA |
|
| holding |
RPRX |
Class A Ordinary Shares |
|
|
|
|
|
1,500 |
11 Feb 2026 |
Direct |
|
| holding |
RPRX |
Class A Ordinary Shares |
|
|
|
|
|
1,450 |
11 Feb 2026 |
By Spouse |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 6,448,180 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,807,277 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.